Tag: FDA approval process for Alzheimer’s drugs
Axsome submits Alzheimer’s disease drug for FDA approval after Phase 3 trials
Axsome Submits Alzheimer’s Disease Drug for FDA Approval
Axsome Therapeutics, a New York-based biotech company, is forging ahead with its plans to seek FDA approval...